Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Web Resources
|
Zacks Investment Research: Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key MetricsNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 23, 2024Digital Resources/Online E-Resources |
|
2 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Level Four Advisory Services LLC Buys 1,844 Shares of CVRx, Inc. (NASDAQ:CVRX)Newstex Global Business Blogs, 2024Copyright Newstex May 20, 2024Digital Resources/Online E-Resources |
|
3 |
Material Type: Web Resources
|
Cost–effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failureHealthcare Economist [BLOG], 2024Copyright Newstex May 30, 2024Digital Resources/Online E-Resources |
|
4 |
Material Type: Web Resources
|
Zacks Investment Research: Why Cytokinetics (CYTK) Stock Price Was Down 17% on ThursdayNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 24, 2024Digital Resources/Online E-Resources |
|
5 |
Material Type: Web Resources
|
Ticker Report - American Consumer News: Trexquant Investment LP Acquires New Holdings in CVRx, Inc. (NASDAQ:CVRX)Newstex Finance & Accounting Blogs, 2024Copyright Newstex Jun 3, 2024Digital Resources/Online E-Resources |
|
6 |
Material Type: Web Resources
|
Defense World - American Consumer News: Trexquant Investment LP Acquires New Holdings in CVRx, Inc. (NASDAQ:CVRX)Defense World [BLOG], 2024Copyright Newstex Jun 3, 2024Digital Resources/Online E-Resources |
|
7 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Brokerages Set CVRx, Inc. (NASDAQ:CVRX) Price Target at $16.60Newstex Global Business Blogs, 2024Copyright Newstex May 29, 2024Digital Resources/Online E-Resources |
|
8 |
Material Type: Web Resources
|
American Banking and Market News - American Consumer News: CVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of “Moderate Buy” by AnalystsNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 26, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Web Resources
|
Defense World - American Consumer News: CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of “Moderate Buy” from BrokeragesDefense World [BLOG], 2024Copyright Newstex May 26, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Trexquant Investment LP Acquires New Shares in CVRx, Inc. (NASDAQ:CVRX)Newstex Global Business Blogs, 2024Copyright Newstex Jun 3, 2024Digital Resources/Online E-Resources |
|
11 |
Material Type: Web Resources
|
Ticker Report - American Consumer News: Analysts Set CVRx, Inc. (NASDAQ:CVRX) Price Target at $16.60Newstex Finance & Accounting Blogs, 2024Copyright Newstex May 29, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Meihua International Medical Technologies (NASDAQ:MHUA) vs. CVRx (NASDAQ:CVRX) Head-To-Head SurveyNewstex Global Business Blogs, 2024Copyright Newstex May 25, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Web Resources
|
Ticker Report - American Consumer News: Analyzing Meihua International Medical Technologies (NASDAQ:MHUA) & CVRx (NASDAQ:CVRX)Newstex Finance & Accounting Blogs, 2024Copyright Newstex May 25, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Web Resources
|
Quantification and Treatment of Congestion in Heart Failure : A Clinical and Pathophysiological Overview Cuantificación y tratamiento de la congestión en insuficiencia cardíaca: una visión clínica y fisiopatológicaopen access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. https://creativecommons.org/licenses/by-nc-nd/4.0Digital Resources/Online E-Resources |
|
15 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Reviewing Windtree Therapeutics (NASDAQ:WINT) and Tarsus Pharmaceuticals (NASDAQ:TARS)Newstex Global Business Blogs, 2024Copyright Newstex Jun 5, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Head to Head Survey: Tarsus Pharmaceuticals (NASDAQ:TARS) & BioCardia (NASDAQ:BCDA)Newstex Global Business Blogs, 2024Copyright Newstex Jun 3, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Web Resources
|
Defense World - American Consumer News: Head to Head Survey: Tarsus Pharmaceuticals (NASDAQ:TARS) & BioCardia (NASDAQ:BCDA)Defense World [BLOG], 2024Copyright Newstex Jun 3, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Web Resources
|
Ticker Report - American Consumer News: Financial Survey: NeurAxis (NASDAQ:NRXS) vs. Integer (NYSE:ITGR)Newstex Finance & Accounting Blogs, 2024Copyright Newstex Jun 1, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Web Resources
|
Zolmax.com - American Consumer News: Comparing NeurAxis (NASDAQ:NRXS) & Integer (NYSE:ITGR)Newstex Global Business Blogs, 2024Copyright Newstex May 30, 2024Digital Resources/Online E-Resources |
|
20 |
Material Type: Web Resources
|
Watchlist News - American Consumer News: Reviewing Meihua International Medical Technologies (NASDAQ:MHUA) & CVRx (NASDAQ:CVRX)Newstex Finance & Accounting Blogs, 2024Copyright Newstex May 21, 2024Digital Resources/Online E-Resources |